Alana Elise Sigmund
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alana Elise Sigmund has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Iturrate
NYU Langone Orthopedics, New York University Langone Medical Center, New York, United States
2 shared publications Ezra Dweck
Division of Pulmonology and Critical Care, Department of Medicine, NYU Langone Medical Center, New York, NY
2 shared publications- Jeanna D. Blitz
Department of Anesthesiology, Duke University School of Medicine, Durham, NC
2 shared publications - Joseph A. Ladapo
Department of Medicine, University of Florida College of Medicine, Gainesville, USA
2 shared publications - Yixin Fang
Department of Mathematical Sciences, New Jersey Institute of Technology, Newark, New Jersey, USA
2 shared publications Aron Mednick
Department of Medicine, New York University School of Medicine, New York, NY
1 shared publication
Latest Publications
- 13 June 2024
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 97, 111522
Expanding the perioperative lens: Does the end justify the means?
- 13 June 2024
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 97, 111522
Expanding the perioperative lens: Does the end justify the means?
- 8 June 2024
- Published by Elsevier in Medical Clinics of North America
- Vol. 108 (6) , 1005-1016
Preoperative Testing
- 8 June 2024
- Published by Elsevier in Medical Clinics of North America
- Vol. 108 (6) , 1005-1016
Preoperative Testing
- 25 June 2018
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 20 (8) , 1-7
Optimizing Rheumatoid Arthritis Patients for Surgery
Purpose of Review The purpose of this review is to guide providers on how best to optimize the health of patients with rheumatoid arthritis (RA) planning surgery, to reduce risk and complications and achieve the best outcomes. Recent Findings The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) have issued a recent guideline on perioperative management of antirheumatic medications in patients with RA. Summary Patients with RA will continue to need surgery. Newer literature is helping to plan the perioperative period to help reduce complications and improve outcomes.
- 25 June 2018
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 20 (8) , 1-7
Optimizing Rheumatoid Arthritis Patients for Surgery
Purpose of Review The purpose of this review is to guide providers on how best to optimize the health of patients with rheumatoid arthritis (RA) planning surgery, to reduce risk and complications and achieve the best outcomes. Recent Findings The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) have issued a recent guideline on perioperative management of antirheumatic medications in patients with RA. Summary Patients with RA will continue to need surgery. Newer literature is helping to plan the perioperative period to help reduce complications and improve outcomes.
- 24 November 2016
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 92 (1) , 98-105
Postoperative Tachycardia
- 24 November 2016
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 92 (1) , 98-105
Postoperative Tachycardia
- 1 October 2016
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 31 (10) , 2348-2352
End Tidal Carbon Dioxide as a Screening Tool for Computed Tomography Angiogram in Postoperative Orthopaedic Patients Suspected of Pulmonary Embolism
- 1 October 2016
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 31 (10) , 2348-2352
End Tidal Carbon Dioxide as a Screening Tool for Computed Tomography Angiogram in Postoperative Orthopaedic Patients Suspected of Pulmonary Embolism
- Open Access
- 1 August 2015
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 175 (8) , 1352-1359
Use of Preoperative Testing and Physicians’ Response to Professional Society Guidance
The value of routine preoperative testing before most elective surgical procedures is widely considered to be low.1-4 The national cost of this testing may be considerable, with 30 million Americans undergoing surgery annually and 60% of those patients undergoing ambulatory procedures.4 In recognition of these challenges and broader concerns about value, several major physician-education initiatives were undertaken to more appropriately guide medical decision making, improve the quality of health care that physicians provide, and reduce the incidence of unnecessary testing. Three in particular—the American Board of Internal Medicine’s “Medical Professionalism in the New Millennium: A Physician Charter,” which helped catalyze the Choosing Wisely campaign5; the American College of Cardiology/American Heart Association (ACC/AHA) update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery6,7; and the American Society of Anesthesiologists’ (ASA) practice advisory guidance for preanesthesia evaluation8—were concurrently disseminated in 2002.
- 1 August 2015
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 175 (8) , 1352-1359
Open AccessUse of Preoperative Testing and Physicians’ Response to Professional Society Guidance
The value of routine preoperative testing before most elective surgical procedures is widely considered to be low.1-4 The national cost of this testing may be considerable, with 30 million Americans undergoing surgery annually and 60% of those patients undergoing ambulatory procedures.4 In recognition of these challenges and broader concerns about value, several major physician-education initiatives were undertaken to more appropriately guide medical decision making, improve the quality of health care that physicians provide, and reduce the incidence of unnecessary testing. Three in particular—the American Board of Internal Medicine’s “Medical Professionalism in the New Millennium: A Physician Charter,” which helped catalyze the Choosing Wisely campaign5; the American College of Cardiology/American Heart Association (ACC/AHA) update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery6,7; and the American Society of Anesthesiologists’ (ASA) practice advisory guidance for preanesthesia evaluation8—were concurrently disseminated in 2002.
- Open Access
- 1 January 2015
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 2 (1) , 39-41
Treatment of Leptomeningeal Carcinomatosis in a Patient With Metastatic Cholangiocarcinoma
A 49-year-old woman with cholangiocarcinoma metastatic to the lungs presented with new-onset unrelenting headaches. A lumbar puncture revealed malignant cells consistent with leptomeningeal metastasis from her cholangiocarcinoma. Magnetic resonance imaging (MRI) of the brain revealed leptomeningeal enhancement. An intrathecal (IT) catheter was placed and IT chemotherapy was initiated with methotrexate. Her case is notable for the rarity of cholangiocarcinoma spread to the leptomeninges, the use of IT chemotherapy with cytologic and potentially symptomatic response, and a possible survival benefit in comparison to previously reported cases of leptomeningeal carcinomatosis secondary to cholangiocarcinoma.
- 1 January 2015
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 2 (1) , 39-41
Open AccessTreatment of Leptomeningeal Carcinomatosis in a Patient With Metastatic Cholangiocarcinoma
A 49-year-old woman with cholangiocarcinoma metastatic to the lungs presented with new-onset unrelenting headaches. A lumbar puncture revealed malignant cells consistent with leptomeningeal metastasis from her cholangiocarcinoma. Magnetic resonance imaging (MRI) of the brain revealed leptomeningeal enhancement. An intrathecal (IT) catheter was placed and IT chemotherapy was initiated with methotrexate. Her case is notable for the rarity of cholangiocarcinoma spread to the leptomeninges, the use of IT chemotherapy with cytologic and potentially symptomatic response, and a possible survival benefit in comparison to previously reported cases of leptomeningeal carcinomatosis secondary to cholangiocarcinoma.